You are using an older browser version. Please use a supported version for the best MSN experience.

Cabinet clears KKR investments in 2 pharma companies

LiveMint logoLiveMint 13-05-2014 PTI

New Delhi: The government on Tuesday cleared private equity major KKR’s proposal to acquire stakes in two pharmaceutical companies in deals worth over Rs1,400 crore, including 38% stake buy in Gland Pharma.

The two deals are estimated to be worth Rs1,434 crore, sources said.

In the first proposal, the Cabinet cleared KKR Floorline Investments PTE Ltd’s acquisition of stake in Hyderabad-based Gland Pharma through a combination of primary investment into the company and share purchase from EILSF, an existing investor.

The private equity major is to snap up 37.98% stake in Gland Pharma.

Besides, the Cabinet gave its nod for another proposal where KKR would acquire 24.9% stake in Gland Celsus Bio Chemicals Pvt Ltd.

In January, fair trade watchdog Competition Commission of India (CCI) approved the deals.

KKR, Gland Pharma and Gland Celsus had entered into the share purchase agreements on 27 November last year. KKR had also entered into a shareholders’ agreement with the promoters of Gland Pharma and EILSF Co-Invest I LLC, an existing private equity investor in Gland Pharma.

Gland Pharma is engaged in the business of production and marketing of specialised injectable formulations for generic versions of drugs, it also manufactures a limited quantity of APIs (Active Pharmaceutical Ingredients) for in-house consumption.

More From LiveMint

image beaconimage beaconimage beacon